Orion reported EUR417.7M in Sales Revenues for its fiscal quarter ending in March of 2026.





Sales Change Date
Almirall EUR 547.63M 12.83M Dec/2025
Hikma Pharmaceutical USD 1.69B 863M Dec/2025
Oriola-kd EUR 502M 38.7M Dec/2025
Raisio Oyj EUR 57.5M 2.3M Mar/2026
Recordati EUR 713.42M 51.42M Mar/2026
UCB EUR 4.25B 764M Dec/2025